AFIMMUNE Trademark

Trademark Overview

On Friday, August 19, 2016, a trademark application was filed for AFIMMUNE with the United States Patent and Trademark Office. The USPTO has given the AFIMMUNE trademark a serial number of 87144934. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, March 4, 2025. This trademark is owned by Afimmune Biopharma Ltd.. The AFIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; scientific research in the field of pharmacy; scientific research for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
afimmune

General Information

Serial Number87144934
Word MarkAFIMMUNE
Filing DateFriday, August 19, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, March 4, 2025
Registration Number5583262
Registration DateTuesday, October 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Goods and ServicesScientific research and development; scientific research in the field of pharmacy; scientific research for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAFIMMUNE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLEOPARDSTOWN, DUBLIN 18
IE
Party NameAFIMMUNE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLEOPARDSTOWN, DUBLIN 18
IE
Party NameAFIMMUNE LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressLEOPARDSTOWN, DUBLIN 18
IE
Party NameAfimmune Biopharma Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeopardstown, Dublin 18
IE

Trademark Events

Event DateEvent Description
Tuesday, August 23, 2016NEW APPLICATION ENTERED
Wednesday, November 9, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 30, 2016ASSIGNED TO EXAMINER
Wednesday, August 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 19, 2017ASSIGNED TO LIE
Monday, July 3, 2017SUSPENSION INQUIRY WRITTEN
Monday, July 3, 2017INQUIRY TO SUSPENSION E-MAILED
Monday, July 3, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 8, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, December 1, 2016SUSPENSION LETTER WRITTEN
Thursday, December 1, 2016LETTER OF SUSPENSION E-MAILED
Thursday, December 1, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 20, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, December 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 15, 2018ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 8, 2018NOTICE OF ALLOWANCE CANCELLED
Friday, December 22, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 8, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, September 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 7, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, September 10, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 10, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 30, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, March 4, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 4, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 4, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, July 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 7, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, July 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 7, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

afimmune scientific research field medical pharmaceuticals clinical trials information providing development